Articles related to GYNECOLOGICAL CANCERS

Cancer Therapy Advisor provides a variety of resources, including regimens used to supplement the most recent treatment strategies. Examine all regimens here.

An ASCO Reading Room selection Fascinating work defining new therapeutic targets and cutting-edge treatment approaches in gynecological cancer is about to come. In this abstract, the authors go over new therapies for gynecologic cancers, such as endometrial, cervical, ovarian, and uncommon gynecologic tumors, and highlight studies that have improved clinicians’ knowledge of the distinct biology and molecular foundations of different tumors, which is being used to develop potent new therapeutic modalities.

In this study of neoadjuvant chemotherapy with ruxolitinib, approximately 130 patients were randomized to receive dose-dense neoadjuvant chemotherapy with or without ruxolitinib, followed by interval debulking and finally three more cycles of dose-dense neoadjuvant chemotherapy with or without ruxolitinib. The ruxolitinib group experienced a 3-month difference in progression-free survival.